Schneider E C, Lieberman T
Division of General Medicine and Primary Care, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA.
Qual Health Care. 2001 Jun;10(2):96-103. doi: 10.1136/qhc.10.2.96.
Public disclosure of information about the quality of health plans, hospitals, and doctors continues to be controversial. The US experience of the past decade suggests that sophisticated quality measures and reporting systems that disclose information on quality have improved the process and outcomes of care in limited ways in some settings, but these efforts have not led to the "consumer choice" market envisaged. Important reasons for this failure include limited salience of objective measures to consumers, the complexity of the task of interpretation, and insufficient use of quality results by organised purchasers and insurers to inform contracting and pricing decisions. Nevertheless, public disclosure may motivate quality managers and providers to undertake changes that improve the delivery of care. Efforts to measure and report information about quality should remain public, but may be most effective if they are targeted to the needs of institutional and individual providers of care.
公开披露有关健康计划、医院和医生质量的信息仍然存在争议。美国过去十年的经验表明,复杂的质量衡量和报告系统能够披露质量信息,在某些情况下以有限的方式改善了医疗过程和结果,但这些努力并未带来预期的“消费者选择”市场。这种失败的重要原因包括客观衡量指标对消费者的显著程度有限、解读任务的复杂性,以及机构采购者和保险公司在合同签订和定价决策中对质量结果的利用不足。尽管如此,公开披露可能会促使质量管理者和提供者进行改善医疗服务的变革。衡量和报告质量信息的努力应保持公开,但如果针对机构和个体医疗服务提供者的需求,可能会最为有效。